We confirmed that RCC tumors contain M2 macrophages by performing immunohistochemistry (IHC) for CD163, a clinically-relevant marker of M2 macrophages [20], in ten consecutive surgical cases of RCC of different subtypes that were excised by one surgeon. Here, CD163 is linked to renal cell carcinoma.